Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Receivables - Other (2020 - 2025)

Abeona Therapeutics has reported Receivables - Other over the past 6 years, most recently at $500000.0 for Q4 2025.

  • Quarterly results put Receivables - Other at $500000.0 for Q4 2025, down 68.75% from a year ago — trailing twelve months through Dec 2025 was $500000.0 (down 68.75% YoY), and the annual figure for FY2025 was $500000.0, down 68.75%.
  • Receivables - Other for Q4 2025 was $500000.0 at Abeona Therapeutics, down from $1.6 million in the prior quarter.
  • Over the last five years, Receivables - Other for ABEO hit a ceiling of $26.3 million in Q2 2022 and a floor of $13000.0 in Q1 2023.
  • Median Receivables - Other over the past 5 years was $1.6 million (2024), compared with a mean of $4.7 million.
  • Biggest five-year swings in Receivables - Other: plummeted 93.73% in 2022 and later soared 17069.23% in 2024.
  • Abeona Therapeutics' Receivables - Other stood at $3.0 million in 2021, then plummeted by 93.73% to $188000.0 in 2022, then surged by 1017.02% to $2.1 million in 2023, then fell by 23.81% to $1.6 million in 2024, then tumbled by 68.75% to $500000.0 in 2025.
  • The last three reported values for Receivables - Other were $500000.0 (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.